PRTA.NASDAQProthena CORP Public LTD CO

Form 4: Director Scully Buys Prothena Shares

Sentiment:

Insider Transaction Filing

📋All filings for Prothena CORP Public LTD CO
🔒Login to Follow

Director William P. Scully acquired 100,000 ordinary shares of Prothena Corp Public Ltd Co for approximately $9.81 per share.

Summary

  • William P. Scully, a Director at Prothena Corp Public Ltd Co, purchased 100,000 ordinary shares on May 22, 2026.
  • The shares were acquired at a weighted average price of $9.813, with individual transaction prices ranging from $9.5499 to $9.9750.
  • Following this transaction, Scully beneficially owns 836,000 ordinary shares directly.
  • Additionally, Scully has indirect beneficial ownership of 80,000 shares through Manatee Equity Fund LLC and 52,000 shares through his spouse.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive filing due to a significant share purchase by a director, indicating insider confidence.

Positives

  • Director's significant share purchase indicates confidence in the company's future prospects.
  • Acquisition of 100,000 shares demonstrates a substantial personal investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider buying, particularly by directors, is often interpreted as a positive signal by the market, suggesting that management believes the company's stock is undervalued or that positive developments are anticipated.

Stakeholder Impact

  • Shareholders may view this purchase positively, potentially leading to increased confidence in the company's stock.
  • Employees may see this as a sign of strong leadership and commitment to the company's success.

Key Dates

DateDescription
05/22/2026Transaction date for the purchase of 100,000 ordinary shares by William P. Scully.
05/26/2026Date of signature for the Form 4 filing.

Recommendation

hold

While insider buying is a positive signal, this Form 4 filing solely reports a transaction and does not provide operational or financial performance data. Therefore, a 'hold' recommendation is appropriate, pending further comprehensive analysis of the company's overall financial health and strategic direction.

Keywords

Prothena Corp, PRTA, Form 4, Insider Trading, Share Purchase, Director, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.